Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 - 2020


Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal sex determination. Until recently, amniocentesis, chorionic villus sampling (CVS), maternal serum screening and nuchal translucency (NT) scan were the primary diagnostic and screening methods for chromosomal abnormalities. Advent of non-invasive prenatal test is poised to eliminate disadvantages associated with these methods, such as low rate of accuracy with maternal serum screening and NT scan, and risk of miscarriage with invasive amniocentesis and CVS procedures. This report on non-invasive prenatal testing market studies the current market scenario and future potential for non-invasive prenatal tests globally.


The major non-invasive prenatal tests studied in this report are BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi and VisibiliT. These tests have been extensively analyzed on the basis of factors such as the technology used, cost to patients, reimbursement coverage, accuracy and geographical reach (availability across various countries). The historical market size and forecast for each of these tests in terms of revenue (USD Million) and volume (Number of tests performed) have been given in the report for the period 2012 to 2020. In addition, the compounded annual growth rate (CAGR) of the overall non-invasive prenatal test market and the above tests has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. The report on non-invasive prenatal testing market also provides comparative analysis of major tests for the years 2013 and 2020.

In this research study, the global market for non-invasive prenatal testing has been geographically segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The non-invasive prenatal testing market size and forecast in terms of revenue (USD Million) and volume (Number of Tests Performed) for each region has been provided for the period 2012 to 2020 along with the CAGR for the forecast period 2014 to 2020. The non-invasive prenatal testing market study also includes qualitative analysis of the competitive scenario in these regions such as major collaboration and partnership, entry of new entrants, new product launch and other macro economic factors. The market overview section of the report on non-invasive prenatal testing market comprises qualitative analysis of the overall non-invasive prenatal testing market considering the factors determining the market dynamics such as drivers, restraints and opportunities along with the Porter’s five force analysis and market attractiveness analysis. The market overview chapter also provides information such as major chromosomal aneuploidies (Down syndrome, Edwards syndrome, Patau syndrome and monosomy X, and their incidence rate, technological approach for NIPT and major patents issued to players operating in the market and other companies and academic research institutions.


The report also includes a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global non-invasive prenatal testing market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the non-invasive prenatal testing market and accentuate market shares. The report concludes with the profiles of major players in the NIPT market such as Sequenom, Inc., Ariosa Diagnostics, Natera, Inc., Illumina, Inc. (Verinata Health, Inc.), BGI Diagnostics, LifeCodexx AG, Laboratory Corporation of America Holdings (LabCorp) and Berry Genomics. Each company profile comprises information such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global non-invasive prenatal testing market is segmented as follows:

Non-Invasive Prenatal Testing Market, by Test
  • BambniTest
  • Harmony
  • informaSeq
  • MaterniT21 PLUS
  • NIFTY
  • Panorama
  • PrenaTest
  • verifi
  • VisibiliT
Non-Invasive Prenatal Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Contact Us:
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/

X-ray Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022


This report on X-ray market studies the current and future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of X-ray devices, and entrants, planning to invest in the X-ray market. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study scope. This section also provides the overall information and data analysis of the global X-ray market with respect to the leading market segments based on types of products, technology, applications and different geographic regions.

Browse Here For Full Report With ToC : http://www.transparencymarketresearch.com/x-ray-market.html

The global X-ray market has been segmented on the basis of product type, technology, application, and geography. On the basis of product type, the market for X-ray is categorized into two major segments, namely, stationary/fixed and portable X-ray systems. The portable X-ray products have been further categorized into two sub-segments, namely, mobile and handheld X-ray systems. Based on technology, the X-ray market is segmented into two major segments, namely, analog and digital X-ray systems. The digital X-ray systems market is further categorized into two major technological systems, namely, computed radiography (CR) and direct digital radiography systems. The market for these segments has been extensively analyzed on the basis of the effectiveness, usefulness, sales revenue, and geographic presence of the X-ray devices. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

On the basis of major types of X-ray detectors that are available in the global market, the X-ray detectors market is categorized into three segments, namely, photostimulable storage phosphor (PSP) detectors, flat panel detectors (FPDs) and other (CCDs, CMOS detectors, etc). Flat panel detectors are further segmented into two categories: Indirect flat panel detectors and direct flat panel detectors. Based upon major application areas, the market is segmented into five categories such as cardiovascular, respiratory, dental, mammography and others (abdominal, orthopedics, general surgery, etc). Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

Requesting For Sample Of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=194

The market overview section of this report explores market dynamics such as drivers, restraints, and opportunities that have strong impact on the X-ray market currently and could influence the market in future as well. The market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market in different geographies. Porter’s five forces analysis is also explained in this section to understand the X-ray market considering different parameters that have an impact on the sustainability of the companies operating in the X-ray market. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Geographically, the X-ray market has been categorized into six regions namely North America, Europe, Asia Pacific, Latin America, Africa, and the Rest of the World (RoW). Market revenue in terms of USD million for the period between 2012 and 2022 along with the CAGR % from 2014 to 2022 are provided for all the regions, considering 2013 as the base year. The recommendations section included in the report would assist existing market players in expanding their market share and new companies in establishing their presence in the X-ray market.

Click Here For Press Release of This Report : http://www.transparencymarketresearch.com/pressrelease/x-ray-market.htm

The report also profiles major players in the X-ray market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Some of the major players profiled in this report include Agfa-Gevaert N.V., Bracco Imaging S.p.A, Canon, Inc., Carestream Health, Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., Hitachi Medical Corporation, Konica Minolta, Inc., Shimadzu Corporation, PerkinElmer, Inc., Philips Healthcare, Siemens Healthcare, Thales group, Toshiba Corporation, Varian Medical Systems, Inc., and Ziehm Imaging, Inc.

The global X-ray market is segmented as follows:

Global X-ray Market, by Product Type

  • Stationary X-ray
  • Portable X-ray
  • Mobile X-ray
  • Handheld X-ray

Global X-ray Market, by Technology

  • Analog X-ray
  • Digital X-ray
  • Computed Radiography
  • Direct Digital Radiography

Global X-ray Detectors Market, by Type

  • Photostimulable Storage Phosphor (PSP) Detectors
  • Flat Panel Detectors
  • Indirect FPDs
  • Direct FPDs
  • Other X-ray Detectors (CCD, CMOS, X-ray Films, etc.)

Global X-ray Market, by Applications

  • Cardiovascular
  • Respiratory
  • Dental
  • Mammography
  • Others (Abdominal, Orthopedic, etc.)

Global X-ray Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Africa
  • Rest of the World (RoW)

About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Contact Us:
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/

Reprocessed Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020


Reprocessing of medical devices refers to the process of inspecting, cleaning, testing, sterilizing and packaging of used and expired medical devices, such that the devices remain effective and safe for suitable clinical application. This study provides the market analysis for various classes and sub-classes of medical devices used for reprocessing. The stakeholders of this report include original equipment manufacturing companies and companies involved in medical device reprocessing and distribution of reprocessed devices as well as new entrants.
The market overview section of the report analyzes the market dynamics and trends such as drivers, restraints and opportunities that would affect the current and future scenario of the reprocessed medical devices market. Porter’s five forces analysis is included in this study to provide thorough analysis about the competitive status of the current reprocessing industry, and market attractiveness analysis has been added to describe the market outlook in different geographies. Event impact analysis is provided in this report for brief understanding of the important events that have taken place in the past and are planned for the future, which might have a major impact on industry growth. Value chain analysis of the market is also discussed in this section to recognize value-creating activities from a number of processes, which would provide an overall understanding of the science of medical device reprocessing.
This market study on reprocessed medical devices has been classified based on various types of devices, which are generally used for reprocessing such as cardiovascular devices, general surgery devices, laparoscopic devices, orthopedic devices and gastroenterology devices. Furthermore, for estimating the overall reprocessed medical devices market, each of the major classes mentioned above have been categorized into several sub-classes of reprocessable medical devices. Cardiovascular devices have been segmented into blood pressure cuffs/tourniquet cuffs, diagnostic electrophysiology catheters, electrophysiology cables, cardiac stabilization and positioning devices. General surgery devices have been segmented into balloon inflation devices and infusion pressure bags. Likewise, laparoscopic devices have been segmented into endoscopic trocars and components as well as harmonic scalpel. Similarly, external fixation devices have been considered for estimating the market of reprocessed orthopedic devices and biopsy forceps have been considered under gastroenterology devices. Market revenue for reprocessed medical devices as well as total devices has been provided in the report for the period 2012 to 2020 in terms of USD million, along with CAGR for the forecast period 2014 to 2020, considering 2013 as the base year. In addition, volume data for each of these devices is provided in the report from 2012 to 2020, with a forecast period from 2014 to 2020.
From the geographical perspective, the global reprocessed medical devices market has been segmented into four major regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). The market revenue of reprocessed medical devices for each geographical market for 2012 and 2020 along with forecast from 2014 to 2020 in respective regions in terms of USD million and value %, respectively has been explained in the geography section of the report.
The report provides company profiles of major players operating in the reprocessed medical devices market. Additionally, detailed market share analysis of the leading players has been provided which includes companies such as Centurion Medical Products Corporation, Hygia Health Services, Inc., Medline ReNewal, MidWest Reprocessing Center, ReNu Medical, Inc., SterilMed, Inc., Stryker Sustainability Solutions, Inc., SureTek Medical and VANGUARD AG. The elaborated market share analysis of the companies involved in the market would help new business participants to identify product portfolio of the established companies and understand the business strategies followed by major companies for sustaining in the market.
The global reprocessed medical devices market is segmented as follows:
Reprocessed Medical Devices Market, by Type of Devices
  • Cardiovascular Medical Devices
    Blood Pressure Cuffs/Tourniquet Cuffs
    Cardiac Stabilization And Positioning Devices
    Compression Sleeves (DVT)
    Diagnostic Electrophysiology Catheters
    Electrophysiology Cables
  • Laparoscopic Medical Devices
    Endoscopic Trocars And Components
    Harmonic Scalpels
  • Orthopedic/ Arthroscopic Medical Devices
    External Fixation Devices
  • Gastroenterology Medical Devices
    Biopsy Forceps
  • General Surgery Medical Devices
    Balloon Inflation Devices
    Infusion Pressure Bags
Reprocessed Medical Devices Market, by Geography

  • North America
  • United States
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Contact Us:
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/

Breast Pumps Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022


Breast pumps are referred to as the medical devices used by lactating mothers to express milk. Additionally these devices are also used to establish milk supply and help relive engorged breasts. These devices are regulated by the U.S. Food and Drug Administration. These pumps are designed to mimic the suckling action of the nursing baby and can act as a supplement to breastfeeding. The demand for these devices is increasing due to the rising number of working women and their growing disposable incomes. Consistent technological advances followed by introduction of breast pumps with enhanced pumping capacity, variable suction pressures, ease of operation will further enhance the acceptance of breast pumps across the globe. On the other hand high cost of these devices and strenuous maintenance of these devices are some of the limiting factors that might restrain the market growth.


There are several types of breast pumps available in the market such as manual, single electric, double electric and hospital grade breast pumps. Pediatrician, lactation consultants and mid wives represent the healthcare professionals who impose a strong influence on the product purchase by the lactating mothers. The breast pumps market has been segmented by the product type into four major categories namely manual, single electric, double electric and hospital grade breast pumps.
This report studies the market for breast pumps by product type. The global breast pumps market has been segmented by product type and market size estimates and forecasts for the period 2012 to 2022 have been provided for each of the segments and sub-segments, in terms of revenue (USD million) and volume (no. of units). The CAGR (%) of each market segment for the forecast period 2014 to 2022 has been provided along with market size estimations, considering 2013 as the base year.


The market has also been segmented geographically into four regions, namely, North America, Europe, Asia and RoW, and the respective market sizes and forecasts in terms of revenue and volume have been provided for each of these regions. These regions are further broken down by major countries. The current and future market sizes (in terms of USD million) of the mentioned regional markets and their major countries have been provided in the report for the period 2012 to 2022 with their growth rate (%) for the period 2014 to 2022. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and flourish in the global breast pumps market.

The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints and opportunities that influence the current and future status of this industry. Impact factors such as event impact analysis, market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global breast pumps market. The competitive landscape section includes market share analysis of all the leading players in this market, for the year 2013.


The report concludes with the company profiles which incorporates key information such as product portfolio and business strategies about the major market players. Some of the major players profiled in this report include Medela, AG, Philips AVENT, Ameda Breastfeeding Solutions, Lansinoh Laboratories, Inc., Whittlestone, Inc., Hygeia Medical Group, and Bailey Medical.

The global breast pumps market is segmented into the following categories:
Breast Pumps Market, by Product Type
  • Manual Pumps
  • Single Electric Breast Pumps
  • Double Electric Breast Pumps
  • Hospital Grade Breast Pumps
Breast Pumps Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • India
  • Japan
  • Rest of Asia Pacific
  • Rest of the World (RoW)
  • Brazil
  • South Africa
  • Mexico
  • Rest of Row
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Contact Us:
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/

Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

The global erectile dysfunction drugs market is led by North America and the region will continue to maintain its leading position during the forecast period owing to the presence of major erectile dysfunction drugs such as Viagra and Cialis.

The erectile dysfunction drugs market report offers an insightful and in-depth assessment of the structure and various elements of the erectile dysfunction drugs market. The report provides a comprehensive introduction of the market, together with industry history, product and geographical classification, and value chain analysis. Key aspects such as production, supply and consumption analysis, price cost and profit evaluation, growth drivers and inhibitors, and details regarding imports and exports have been provided in the erectile dysfunction drugs report with critical insights and recommendations.


Overview of the global erectile dysfunction drugs market

The worldwide erectile dysfunction drugs market is primarily driven by growing geriatric population, rise in incidences of numerous diseases, preference towards sedentary lifestyle, and increasing focus on patient education and awareness. In addition to this, the growing impact of generics, ongoing clinical trials and tests for erectile dysfunction drugs, blockbuster patent expirations, innovative drug delivery techniques, and new molecule combinations are some of the areas that hold immense growth opportunities for the erectile dysfunction drugs market.

On the other hand, diminishing insurance coverage for the treatment of erectile dysfunction, increasing threat from counterfeit drugs, weak pipeline development, and increasing prevalence of sexually transmitted diseases (STDs) among users of erectile dysfunction drugs are expected to hamper the growth of the market. Moreover, the expectant patent expiration of Eli Lilly & Co.’s Cialis and Bayer AG’s Levitra, and that of industry leader Pfizer’s Viagra outside the U.S. in 2013 is estimated to greatly impact the erectile dysfunction drugs market.


Geographically, North America led the global erectile dysfunction drugs market and was estimated to be worth US$2,098.4 million in 2012. While patent expiration of blockbuster erectile dysfunction drugs is expected to restrain the growth of the erectile dysfunction drugs market in developed regions, their increasing adoption in emerging economies is expected to drive the global erectile dysfunction drugs market.

Companies mentioned in the research report

The research report on erectile dysfunction drugs market profiles the leading players operating in the market. Highlighting individual strengths, weakness, opportunities, and threats, the report offers a detailed analysis on the various participants in the erectile dysfunction drugs market. It also tracks and anticipates numerous trends and developments in the competitive landscape and offers critical and strategic recommendations based on data provided by authentic sources within the erectile dysfunction drugs market. The companies mentioned in the erectile dysfunction drugs market report are Meda Pharmaceuticals, Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda., Vivus, Inc., Eli Lilly And Company, Apricus Biosciences, Inc., Dong-A Pharmaceutical Co. Ltd., Pfizer, Inc., S.K. Chemicals Co. Ltd., and Bayer AG.


Among these, Viagra by Pfizer, Inc. dominated the erectile dysfunction drugs market in 2012, followed by Eli Lilly & Co.’s Cialis and Bayer AG’s Levitra.

Major geographies analyzed under this research report are:
  • EMEA
  • North America
  • Asia-Pacific
  • Rest of the World
This report gives you access to decisive data such as:
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years
Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments.
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Contact Us:
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/

Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022


meningitis, is one of the most catastrophic infections among individuals or communities. Several meningococcal serogroups have been identified till date, of which serogroups A, B, C, Y, and W-135 are the most prominent ones causing the infection. Meningococcal disease is a life threatening condition and potentially fatal illness caused due to the bacterium Neisseria meningitidis. It causes serious infection of the thin layers of connective tissue surrounding the brain and spinal cord called the meninges. Immunization by vaccines has been of great help to public health. It has saved millions of children and provided them with a chance of better and healthier life. Many diseases have been eradicated, while some have been better controlled. Thus vaccines are considered as the most powerful form of all preventive measures. Meningococcal disease is one such disease which has a high mortality rate if left undiagnosed and untreated. Meningococcal vaccines are used to prevent diseases such as meningitis, meningococcemia and septicemia, caused due to N. meningitidis.Meningococcal disease, especially meningococcal 
According to a report by CDC, incidences of bacterial meningitis have dropped by almost a third over the past decade due to stringent regulations, awareness and initiatives taken by the government as well as the citizens. The global meningococcal vaccines market is studied on the basis of vaccine types such as polysaccharide, conjugate, and combination vaccines that are further segmented into different brands. The report also highlights and analyzes various brands of Men B vaccines recently approved, such as Bexsero and Trumenba, as well as the vaccine currently in pipeline - NmVac-4DT. A detailed market analysis and forecast for these segments has been provided in this study, in terms of revenue (USD million) for the period 2012 to 2022. The report also provides the compounded annual growth rate (CAGR %) for each meningococcal vaccine segment and brand for the forecast period 2014 to 2022, while market size estimations have been made considering 2012 and 2013 as the base years.
In terms of geographical distribution, the global meningococcal vaccines market has been classified into four major geographical areas, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The regions are further broken down by major countries. The current and future market sizes (in terms of USD million) of the mentioned regional markets and their major countries have been provided in the report for the period 2012 to 2022 with their growth rate (%) for the period 2014 to 2022. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and flourish in the global meningococcal vaccines market.
The global meningococcal vaccines market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints and opportunities that influence the current and future status of meningococcal vaccines industry. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the global meningococcal vaccines report, in order to give a thorough analysis of the overall competitive scenario in the global meningococcal vaccines market. The global meningococcal vaccines market report also covers qualitative information on certain areas in market overview section which include clinical features, epidemiology, diagnosis and treatment for meningococcal disease, types of meningococcal vaccines, and regulatory scenario.
The report concludes with the company profiles section which includes key information about the major players in this market. Key players profiled in this report include Sanofi S.A., Novartis International AG, GlaxoSmithKline plc, Pfizer, Inc., Serum Institute of India, Ltd., JN-International Medical Corporation, Nuron Biotech, Baxter International and Biomed Pvt. Ltd.
The global meningococcal vaccines market is segmented as follow:
Meningococcal Vaccines Market, by Type
  • Polysaccharide Vaccines, by Brand
  • Menomune
  • Mencevax
  • NmVac4
  • Others
  • Quadri Meningo
  • Bi Meningo
Conjugate Vaccines, by Brand
  • Menactra
  • Menveo
  • NeisVac-C
  • Nimenrix
  • Meningitec
  • Menjugate
  • MenAfriVac
Combination Vaccines, by Brand
  • MenHibrix
  • Menitorix
  • NmVac4-DT
Men B Vaccines, by Brand
  • Bexsero
  • Trumenba
Meningococcal Vaccines Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • Japan
  • Australia
  • Rest of Asia Pacific
  • Rest of the World
  • Latin America
  • Africa
  • Rest of RoW
About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Contact Us:
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/

Albumin Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2020


Appropriate selection of excipients during the new product development is one of the critical in the pharmaceutical formulations. Criteria for selection of suitable excipient depend on the physical, chemical and biological properties of the excipient. Primarily, it should help stabilize and protect the drug/active pharmaceutical ingredient (API) in the formulation against degradation, oxidation or aggregation, during manufacturing, transport and storage. Preformulation studies comprise investigation of drug-excipient interactions that help in selection of appropriate excipients to achieve the desired properties for the final drug product. Albumin is a well characterized protein and functions as a therapeutic, diagnostic agent, as well as an excipient. As an excipient, albumin has wide applications in drug formulation, drug delivery, vaccine manufacturing and as a component of media in vaccine production. Stable nature of albumin makes its handling and storage easier than other proteins, making it suitable for use as an excipient. Albumin due to its intrinsic stability can be heated at 60°C for 10 hours facilitating virus inactivation during manufacturing.
This report studies the global market for albumin encompassing type, applications and geography. Types of albumin include human serum albumin, bovine serum albumin and recombinant albumin. Major applications for albumin as an excipient comprise drug formulation and drug delivery, vaccines and component of medium. Each of these segments has been analyzed in detail from market trends and recent developments to future outlook and opportunities. The report provides the albumin market size in terms of value (USD million) and volume (kg) for each segment and sub-segment for the period from 2012 to 2020, considering the macro- and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall albumin market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 as historical year and 2013 as the base year. The global albumin market report also includes an elaborate executive summary, which covers a market snapshot representing key findings from the study.
Geographically, the global albumin market has been segmented into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast in terms of value (USD million) and volume (kg) for each of these regions along with the CAGR for the forecast period from 2014 to 2020 have been provided in the report. A detailed qualitative analysis of the major factors determining market dynamics such as drivers, restraints and opportunities, along with the market attractiveness analysis are discussed in the market overview section of the report. The study also provides a list of recommendations for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process. Event impact analysis and clinical pipeline analysis have also been provided for albumin as an excipient in this report that will help in understanding the major events impacting the albumin market growth. Number of clinical trials also demonstrates the potential of albumin use as an excipient in pharmaceutical formulations.
The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. The key players operating in the albumin market are CSL Behring LLC, HiMedia Laboratories Pvt. Ltd., InVitria, MedzBio Pte. Ltd., Mitsubishi Tanabe Pharma Corporation, Novozymes A/S, Octapharma AG, RayBiotech, Inc., Sigma-Aldrich Corporation, and Thermo Fisher Scientific.
The global albumin market is segmented as follows:
Albumin Market Revenue (USD Million), by Type
  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin
Albumin Market Revenue (USD Million) and Volume (kg), by Application
  • Drug Formulation and Drug Delivery
  • Vaccines
  • Component of Medium
Albumin Market Revenue (USD Million) and Volume (kg), by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

About Us :
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Contact Us:
Transparency Market Research
90 State Street, 
Suite 700, 
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http:/www.transparencymarketresearch.com/